Indian Pharmaceutical Supplier to Mauritius.
India is the largest single source of pharmaceutical product in Mauritius, accounting for roughly thirty-nine per cent of the market by value, and the India-Mauritius CECPA preferential agreement (in force since 2021) gives Indian-origin medicines a tariff edge that no other origin can match. Port Louis sits at the centre of the Indian Ocean re-export web reaching Madagascar, Comoros, Seychelles, Reunion and Mozambique. M Care has run the Mumbai-Port Louis lane since the CECPA came into force. If you are a Pharmacy Board-registered importer, a Ministry of Health procurement officer, or a wholesale operator using Mauritius as the IORA hub for onward SADC or COMESA supply, this page is the operational version.
Pharmacy Board, CECPA and the Indian Ocean hub.
The Pharmacy Board, operating under the Ministry of Health and Wellness within the Pharmacy Act 1983 and the Pharmacy Council Act 2015, is the licensing gate for medicines in Mauritius. Wholesale licence holders import against per-product registration; CTD-format dossiers in English are accepted, with French permissible on selected items. The Pharmacy Board recognises WHO-GMP as the manufacturing-site standard and routinely accepts CDSCO-issued Certificates of Pharmaceutical Product in WHO format.
Three structural advantages set the Mauritius lane apart from every other African destination M Care serves. First, the India-Mauritius Comprehensive Economic Cooperation and Partnership Agreement (CECPA), in force since April 2021, gives Indian-origin pharmaceutical products a tariff preference over comparable products from non-Indian sources. Second, English is the working language of pharmaceutical trade and procurement, removing the dossier-translation overhead that complicates francophone West Africa. Third, Mauritius operates an International Financial Services Centre framework that makes settlement and counterparty diligence straightforward by African-market standards.
On the procurement side, the Ministry of Health runs central procurement for state hospitals; private wholesalers handle roughly seventy-five per cent of import volume into private hospital chains, retail pharmacy networks and the IORA re-export channel. The Indian Ocean Rim Association (IORA) status and Mauritius's SADC plus COMESA dual membership make Port Louis a natural staging point for onward supply into Madagascar, Comoros, Seychelles, Reunion and Mozambique, subject to rules-of-origin compliance.
Mauritius itself is the most politically stable, FATF-compliant African pharma market we work in. The country was off the EU AML grey list in 2021 and remains EU AML-compliant, which makes correspondent-banking friction with Indian banks the lowest of any African destination.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST
Six fronts on the Mauritius lane and the IORA hub.
Pharmacy Board registration
End-to-end Pharmacy Board registration packs in CTD format, manufacturer site registration and per-product files. English-language submissions with French variants where the molecule profile or the importer's preference requires it. First-time generic registration runs 8 to 12 months.
CECPA tariff-edge supply
Indian-origin product into Mauritius under the CECPA tariff preference. Origin certification handled at source by our authorised chamber-of-commerce documentation team, with FORM-CECPA on every consignment so the customs duty saving lands at the importer's account.
Indian Ocean re-export hub
Port Louis as a staging point for onward supply into Madagascar (TGE), Comoros, Seychelles (SEZ), Reunion (DOM) and Mozambique. Rules-of-origin compliance handled at consignment level for SADC and COMESA secondary moves.
Private wholesale supply
Private wholesalers handle ~75% of Mauritian pharma import volume; we supply into that channel directly. Cold-chain biologicals, oncology injectables, branded generics and specialty injectables on weekly call-off where forecasts justify it.
Ministry of Health procurement
Central state-sector tender response for the Mauritius Ministry of Health: WHO-EML backbone, hospital pharmacy fill, biosimilars and the cold-chain biologic shelf. Submissions on the MoH e-procurement template with English-language dossier files.
Mumbai to Port Louis freight
Air via direct freight on Air India and Air Mauritius BOM-MRU, 5 to 7 hours wheels-up. Sea via Mumbai (Nhava Sheva) to Port Louis on direct services from Maersk and CMA CGM, 12 to 14 days transit. Cold-chain on validated Envirotainer and Pelican BioThermal lanes.
How stock actually clears Port Louis Customs and onward.
Port Louis is the sole commercial port on the island and handles the full Mauritian pharmaceutical import flow. Sea freight from Mumbai (Nhava Sheva) to Port Louis runs 12 to 14 days transit on direct services from carriers including Maersk and CMA CGM, with customs clearance at the Mauritius Revenue Authority typically completing inside three to four working days for compliant CTD-backed pharma cargo. The CECPA preferential certificate of origin is verified at this stage; we issue it at source through an authorised chamber-of-commerce so the duty saving lands at the importer rather than getting lost in port-side paperwork.
Air freight is the cold-chain and time-sensitive option. Direct services BOM to MRU on Air India and Air Mauritius cover the lane in 5 to 7 hours wheels-up to wheels-down. Validated Envirotainer RKN e1 and Pelican BioThermal Credo Cube cover 2 to 8 degree celsius bulk and smaller consignments respectively, with continuous Sensitech temperature logging through to the receiving wholesaler's bonded warehouse.
Where Mauritius differentiates from every other African lane is the onward re-export potential. Port Louis sits at the centre of the Indian Ocean Rim, and SADC plus COMESA dual membership means Mauritius-cleared product can move into Madagascar, Comoros, Seychelles, Reunion and Mozambique under preferential rules-of-origin treatment, subject to consignment-level SADC or COMESA certification. We assemble the rules-of-origin documentation chain at consignment level so the secondary move is friction-free.
Commercial terms on the Mauritius lane are among the cleanest M Care runs into Africa. USD or EUR LC at sight is the standard for first-time engagements; documentary collection and open account 30 days follow once the relationship settles. The IFSC framework and the country's FATF-compliant status mean that correspondent banking through Indian institutions is faster and cheaper than any other African destination.
What Mauritian buyers actually ship through Port Louis.
Mauritius is a small absolute market (~1.27 million population) but with an above-African-average healthcare spend per capita and an upper-middle-income procurement profile. The Ministry of Health buys to the WHO Essential Medicines List backbone with biosimilar oncology, anti-infective and cardiovascular lines; private wholesalers move the chronic-disease and specialty-injectable shelf into private hospitals and the retail pharmacy network.
Our highest-volume Mauritius therapy areas are cardiovascular (statins, ACE inhibitors, beta-blockers, the DOAC bench) and diabetes (insulins, oral antidiabetics with the analogue biosimilar bench growing) on the chronic-disease side, plus oncology and supportive-care lines on the specialty side. Anti-infectives are the steady volume backbone; cold-chain biologicals are the fastest-growing slice on both state and private channels.
Where Mauritius adds a layer that most African markets do not is the IORA re-export angle. Madagascar pharma demand running through Port Louis is a real volume driver on cardiovascular and anti-infective lines; Reunion (as a French overseas department) draws specialty injectables into private hospital networks; Comoros and Seychelles draw lower-volume but consistent chronic-disease formularies. We assemble the rules-of-origin chain at consignment level so onward moves under SADC or COMESA preferential rules ship without a documentation re-package.
A Port Louis private wholesaler came to us in 2024 needing CECPA-eligible supply on a cardiovascular line where the previous-origin product had lost preferential status. We identified a Pharmacy Board-registered SKU from one of our Gujarat partners, prepared CECPA-compliant FORM-CECPA documentation at source and shipped a validated trial container from Nhava Sheva to Port Louis inside fourteen days. The wholesaler carried the molecule forward on a 24-month supply agreement and added two Madagascar re-export lines once the SADC rules-of-origin chain cleared. Customs duty saving on the CECPA-eligible volume: meaningful and recurring.
Why M Care fits the Mauritian operator's brief.
Mauritius is the most professional pharmaceutical-import market M Care works in Africa. Procurement is English-language, the Pharmacy Board recognises WHO-GMP and CDSCO documentation cleanly, the CECPA agreement gives Indian-origin product a tariff edge, and the IFSC framework keeps banking friction at the lowest level on the continent. The question for a Port Louis importer is not whether Indian pharma works; it is which Indian counterparty handles CECPA documentation correctly at source, fits the rules-of-origin chain that the IORA re-export plan needs, and can ship validated cold-chain consignments onto a fourteen-day sea schedule without surprises.
M Care brings the Mumbai HQ as the source of supply, an authorised chamber-of-commerce CECPA documentation team, validated cold-chain operations on the BOM-MRU air lane and the Mumbai-Nhava Sheva to Port Louis sea lane, plus the rules-of-origin documentation chain for onward SADC and COMESA moves. Where the importer's plan is Mauritius-only, we deliver into Pharmacy Board-registered wholesalers and Ministry of Health tender desks with English-language dossiers and CECPA-preferential pricing. Where the plan is Mauritius-plus-onward, we assemble the rules-of-origin chain at consignment level so the Madagascar, Reunion or Mozambique secondary move ships without a documentation re-package.
What Port Louis buyers ask us first.
Are your Indian manufacturing partners Pharmacy Board-registered?
Yes, on every molecule we actively quote into Mauritius. The Pharmacy Board accepts WHO-GMP as the manufacturing standard and routinely accepts CDSCO-issued Certificates of Pharmaceutical Product. We can provide the latest WHO-GMP inspection report, Site Master File extract and batch Certificate of Analysis ahead of any trial order so your QA team can sign off before a purchase order is raised.
How does the India-Mauritius CECPA tariff preference work in practice?
Under the CECPA in force since April 2021, Indian-origin pharmaceutical products qualify for preferential tariff treatment on import into Mauritius, lower than the standard MFN duty. The duty saving lands at the importer's account when FORM-CECPA is presented at customs. We issue FORM-CECPA at source through an authorised chamber-of-commerce on every CECPA-eligible consignment, so the importer is not chasing origin paperwork after the cargo lands.
Can Mauritius act as a re-export hub into Madagascar, Comoros or Reunion?
Yes, subject to consignment-level rules-of-origin documentation. Mauritius is a SADC and COMESA member; Port Louis-cleared product can move into SADC (Madagascar, Mozambique) and COMESA neighbours under preferential rules, and into Reunion as a French overseas department under separate import documentation. We assemble the rules-of-origin chain at consignment level for the secondary move.
What is the lead time on a Mumbai to Port Louis shipment?
Air via Air India or Air Mauritius BOM-MRU direct: 36 to 60 hours door-to-door including airport clearance. Sea via Mumbai (Nhava Sheva) to Port Louis on Maersk or CMA CGM: 12 to 14 days transit plus 3 to 4 days clearance. Cold-chain on validated Envirotainer or Pelican BioThermal lanes with continuous Sensitech logging.
Do you supply both the state and the private channels?
Yes. The Ministry of Health runs central tender procurement for the state channel; we bid these through Pharmacy Board-registered importers. Private wholesalers handle ~75% of import volume into private hospital chains and retail pharmacy; we supply that channel directly with adapted documentation packs and pricing structures.
What banking and settlement arrangements do you support?
USD or EUR LC at sight is the standard for first-time engagements; documentary collection and open account 30 days follow once the relationship settles. Mauritius's IFSC framework and FATF-compliant status mean correspondent-banking friction is the lowest of any African market, and Indian-bank routing through SBI and ICICI to Mauritian commercial banks is straightforward.
Why Port Louis buyers choose M Care.
CECPA tariff edge, source-issued
FORM-CECPA on every CECPA-eligible consignment, issued at source through an authorised chamber-of-commerce. The duty saving lands at the importer rather than getting lost in port-side paperwork.
IORA re-export ready
Mauritius-cleared product onward into Madagascar, Comoros, Seychelles, Reunion and Mozambique under SADC or COMESA preferential rules. Rules-of-origin chain assembled at consignment level, no re-package needed.
Lowest-friction African banking
FATF-compliant Mauritius and IFSC framework mean correspondent banking through Indian institutions is the cheapest and fastest of any African destination M Care serves.
Top categories we ship to Mauritius
Cardiovascular
Statins, ACE inhibitors, beta-blockers, DOACs and the heart-failure shelf for chronic-disease procurement.
Diabetes & endocrine
Insulins, oral antidiabetics, thyroid therapy, hormonal therapy.
Oncology
Paclitaxel, gemcitabine, oxaliplatin, biosimilars and supportive-care lines.
Anti-infectives
Penicillins, cephalosporins, carbapenems, antivirals, antimalarials — 1,800+ lines.
Respiratory
Inhalers, nebuliser solutions, ICS-LABA combinations — 117+ SKUs.
General & OTC
Analgesics, vitamins, wound-care, nutritionals for retail pharmacy.
Routes that sit behind the Mauritius lane.
WHO-GMP compliance
Manufacturer registration and Site Master File support that Pharmacy Board recognises on first pass.
CTD dossier preparation
Pharmacy Board-ready CTD dossiers in English, with French variants where the molecule profile or importer preference requires.
Cold-chain validated supply
Validated 2 to 8 degree celsius lanes from Mumbai to Port Louis with continuous Sensitech logging through to the receiving wholesaler.
CECPA-priced, IORA-ready, English-documentation.
Your enquiry goes directly to the account manager responsible for the Mauritius desk. CECPA tariff preference factored into the quote on receipt.
Start a Mauritius enquiry → Back to all markets